Patient Centered Intervention to Prevent Tuberculosis Among Children Under Five Years Old
NCT03881228 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 356
Last updated 2024-04-15
Summary
Isoniazid preventive therapy (IPT) reduces the risk of tuberculosis in 60%. Young children are at higher risk of developing severe forms of TB, though this can be prevented with a full course of IPT. Preliminary data indicate that 60% of eligible children start IPT, and 30% complete it. Furthermore, children can be exposed to more than one case of TB in the household. Adults exposed to TB in the household setting are not necessarily aware of their risk. Uncertainties in the decisions of staff to prescribe IPT and limited health literacy among caretakers and families contribute to this. The investigators will determine the efficacy of an intervention package to increase IPT adherence and completion among children \< 5 years old exposed to TB in the household. The investigators will assess the efficacy of the intervention by 1) measuring IPT completion at 6 months after treatment initiation and by 2) determining adherence to IPT by measuring isoniazid in urine at weeks 2, 8 and 24 in a random cluster sample of 10 health facilities and 20 control facilities with 10 children included in each facility (100 in intervention and 200 in control). The investigators will measure fidelity and reach, and acceptability among caretakers and health staff. The intervention package will consist of: 1) educational booklet for caretakers explaining why IPT needs to be given 2) a children's storybook, with weekly installments, over the 6-month course of IPT as a non-monetary incentive and 3) short messages services (SMS) reminders delivered to the caretaker for the weekly pick-up
In September 2020, the protocol was updated to adapt to the COVID19 situation in Lima. One of the secondary outcome (isoniazid concentration in urine) was cancelled and the full intervention (educational booklet, weekly children storybook and weekly SMS) is now delivered through WhatsApp.
Conditions
- Tuberculosis
- Pediatric ALL
- Behavior, Health
Interventions
- BEHAVIORAL
-
Increasing the completion of IPT
Behavioral intervention with three components to increase the completion of IPT among children
Sponsors & Collaborators
-
Universidad Peruana Cayetano Heredia
lead OTHER
Principal Investigators
-
Larissa Otero, MD PhD · Universidad Peruana Cayetano Heredia
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 1 Day
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-12-01
- Primary Completion
- 2023-08-15
- Completion
- 2023-08-15
Countries
- Peru
Study Locations
More Related Trials
-
Infant TB Infection Prevention Study
NCT02613169 ·Status: COMPLETED ·Phase: PHASE2
-
Implementation of an Integrated Care Strategy for Children Contacts of Patients With Tuberculosis
NCT04331262 ·Status: COMPLETED
-
A Multicentre, Cohort Study of Screening and Preventive Intervention for Latent Tuberculosis Infection in Children
NCT04156568 ·Status: UNKNOWN ·Phase: PHASE1
-
Introduction of Dispersible 3HP Formulations for TB Preventive Treatment in Children: a Multi-country Evaluation
NCT06511180 ·Status: NOT_YET_RECRUITING
-
Integrating Pediatric TB Services Into Child Healthcare Services in Africa
NCT03862261 ·Status: COMPLETED ·Phase: NA
-
Tuberculosis In Children Visiting Friends and Relatives
NCT04236765 ·Status: UNKNOWN ·Phase: NA
-
Promoting Adherence to TB Regimens in Latino Adolescents
NCT00005738 ·Status: COMPLETED
-
TB Case-Finding, Treatment and Prevention Intervention in Thailand
NCT05581212 ·Status: COMPLETED ·Phase: NA
-
Finding and Treating Unsuspected and Resistant TB to Reduce Hospital Transmission
NCT02355223 ·Status: UNKNOWN ·Phase: NA
-
A Study of Daily Rifapentine Combined With Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age With and Without HIV
NCT07124559 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Diagnosing Tuberculosis in HIV Infected Children in Peru
NCT00054769 ·Status: COMPLETED
-
Impact of Systematic Early Tuberculosis Detection Using Xpert MTB/RIF Ultra in Children With Severe Pneumonia in High Tuberculosis Burden Countries (TB-Speed Pneumonia)
NCT03831906 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Active Case Finding of Household Contacts in a Routine Tuberculosis (TB) Control Program
NCT02174380 ·Status: UNKNOWN ·Phase: NA
-
Diagnostic Innovations for Pediatric Tuberculosis in Bolivia
NCT06113861 ·Status: RECRUITING
-
Mobile Health Intervention for Active Tuberculosis
NCT03544476 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Public Health Model of Latent Tuberculosis Infection Control for High-Risk Adolescents
NCT00233168 ·Status: COMPLETED ·Phase: NA
-
Isoniazid Prophylaxis With Concomitant Cotrimoxazole in HIV-infected Children
NCT00330304 ·Status: COMPLETED ·Phase: PHASE3
-
Tuberculosis Immunity in Children
NCT00170638 ·Status: COMPLETED
-
Digital Health Intervention to Improve TPT Uptake
NCT07313995 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Qualitative Understanding of Community TB Services Pre and Post the CHIP-TB Trial
NCT04494516 ·Status: COMPLETED
-
Preventing Childhood Tuberculosis in Lesotho (PREVENT Study)
NCT02662829 ·Status: COMPLETED ·Phase: NA
-
Prevalence of Latent Tuberculosis in High Risk Children
NCT03910946 ·Status: UNKNOWN
-
Impact of an Innovative Childhood TB Diagnostic Approach Decentralized to District Hospital and Primary Health Care Levels on Childhood Tuberculosis Case Detection and Management in High Tuberculosis Incidence Countries (TB-Speed Decentralisation)
NCT04038632 ·Status: COMPLETED ·Phase: NA
-
Dolutegravir Pharmacokinetics During Weekly Rifapentine/Isoniazid for TB Prevention
NCT06281834 ·Status: RECRUITING ·Phase: PHASE1
-
Shortened Regimen for Drug-susceptible TB in Children
NCT06253715 ·Status: RECRUITING ·Phase: PHASE3